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Despite the decline in coronary heart disease in many Euro-pean countries, the disease remains an enormous public
health problem. Although we know a great deal about environ-
mental risk factors for coronary heart disease, a heritable
component was recognized a long time ago. The earliest and
best known examples of how our genetic constitution may
determine cardiovascular risk relate to lipoprotein(a), familial
hypercholesterolaemia and apolipoprotein E. In the past 
20 years a fair number of polymorphisms assessed singly have
shown strong associations with the disease but most 
are subject to poor repeatability. Twins constitute a compelling
natural experiment to establish the genetic contribution to
coronary heart disease and its risk factors. GenomEUtwin, 
a recently funded Framework 5 Programme of the European
Community, affords the opportunity of comparing the heritabil-
ity of risk factors in different European Twin Registries. As an
illustration we present the heritabilities of systolic and diastolic
blood pressure, based on data from over 4000 twin pairs from
six different European countries and Australia. Heritabilities for
systolic blood pressure are between 52 and 66% and for dias-
tolic blood pressure between 44 and 66%. There is no
evidence of sex differences in heritability estimates and very
little to no evidence for a significant contribution of shared
family environment. A non-twin based prospective case/cohort
study of coronary heart disease and stroke (MORGAM) will
allow hypotheses relating to cardiovascular disease, generated
in the twin cohorts, to be tested prospectively in adult popula-
tions. Twin studies have also contributed to our understanding
of the life course hypothesis, and GenomEUtwin has the
potential to add to this.
As early as 1819, Samuel Black (Evans, 1995) the Irish
physician, in reviewing angina pectoris, noted: 
We have seen that the disease appears to be connected with
a plethoric state of the system and with obesity: that the
great majority of the subjects of it have belonged to the
better ranks of society, who were in the habit of sitting
down everyday to a plentiful table, in the pleasures of which
they may have indulged to a greater extent than was suitable
to the tendency of their constitution …
He plainly recognized a genetic contribution to coronary
heart disease (CHD). 
The Genetics of Lipid Metabolism
The best examples of the genetic contribution to cardiovas-
cular risk relate to lipid metabolism. Much has been learnt
concerning the genetics of cholesterol, its sub-fractions and
its lipoproteins. The story began with the report (Berg,
1963) that lipoprotein(a) is a heritable risk factor for cardio-
vascular disease. This is an altered form of low density
lipoprotein cholesterol (LDL) with a large glycoprotein
bonded to the apolipoprotein B100 moiety of low density
lipoprotein cholesterol; the protein bears a striking resem-
blance to plasminogen, and there appears to be cross
reactivity between them.
One well known and serious defect in cholesterol
metabolism is familial hypercholesterolaemia (Brown 
& Goldstein, 1986). The heterozygous state of this autoso-
mal dominant condition, present in around 1 in 500 of
most western populations, is associated with elevated choles-
terol and premature CHD. The homozygous state leads to
accelerated vascular disease and, without treatment, survival
into the teenage years is unusual. The unravelling of recep-
tor mediated endocyclasis is a fascinating story. The
underlying problem is a deficiency in LDL cholesterol
receptors and so cholesterol accumulates in inappropriate
places, e.g., the walls of arteries. Similarly, if there is a muta-
tion in the codon for the amino acid 3500 in apolipoprotein
B100, hypercholesterolaemia results (Farese et al., 1992).
Thankfully, however, this “Familial Defective Apo B” is even
rarer than familial hypercholesterolaemia.
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By convention when these genetic variations are
common we refer to them as polymorphisms. Examples
include single nucleotide polymorphism or SNPs. Such
SNPs may occur at sites which have no effect on gene
function or they may occur in coding regions (resulting 
in an altered function of the gene product) or in gene reg-
ulatory elements (resulting in altered quantities of the gene
product being produced). It is this combination of 30–40
small differences in each of 30–40,000 genes which 
makes us different from one another — and different 
from anyone who has ever lived or will live (Payne 
& Montgomery, 2002). 
One of the best known and well-elucidated of these
polymorphisms affects apolipoprotein E. In the ECTIM
study (a case control study of myocardial infarction) which
was mounted between the WHO-MONICA (MONItoring
in CArdiovascular disease) project centers in Belfast, Lille,
Strasbourg and Toulouse, male patients aged 25–64 years
were recruited (Luc et al., 1994). Despite a three-fold
higher level of CHD in Northern Ireland than in France,
classical risk factor levels were very similar. A total of 574
cases and 722 controls were available for a comparison 
of apolipoprotein E phenotype and genotype. Competition
by Apo B and Apo E for the LDL receptor (the avidity of
the receptor being determined genetically) explained the
different atherogenic potentials, with the ε4 allele being
associated with higher levels of LDL cholesterol and conse-
quently a greater susceptibility to atherosclerosis. The 
ε2 allele favors peripheral LDL catabolism. The relative
risks associated with the ε2 and ε4 alleles were 0.73 and
1.33, respectively, suggesting that 12% of myocardial
infarction might be attributable to this polymorphism. The
ε4 allele frequency was 14.3%, 14%, 10.8% and 5.2% in
Belfast, Lille, Strasbourg and Toulouse, respectively (simi-
larly, the prevalence of ε2 was 10.3%, 11.9%, 8.5% and
5.6%). There is even greater variation around the world
with an ε4 allele frequency ranging from over 30% in
Nigeria to less than 5% in Japan (Cambien, 1994). It has
also been shown (Amouyel et al., 1994) that ε4 allele carri-
ers have a several-fold risk of developing Alzheimer’s disease
and a lesser risk of developing Creutzfeldt-Jakob disease.
An alternative strategy to studying people who become
ill and die prematurely is to study those who survive into
extreme old age. In the United Kingdom reaching 100
years of age attracts a message from Royalty; not so in
France where such prodigious age will attract a researcher,
complete with needle and syringe, to acquire white cells
for the extraction of DNA. A total of 338 Centenarians
were assembled (Schächter et al., 1994) in this way, 294
(87%) of whom were women. The ε4 allele was less
common than expected whereas the ε2 allele was more
common, indicating selective survival/mortality in the
presence of these two alleles. 
The better understanding of such gene–environment
interactions in relation to CHD and factors such as diet
may greatly refine treatment in the future, and explain why
the classic risk factors are often imprecise in defining an
individual’s risk. Rare mutations with big effects are disas-
trous for the individual but have small population impact,
whereas common polymorphisms with small effects may
together produce common diseases and carry a large popu-
lation impact.
This may sound plausible enough, but when one con-
siders that there might be several hundred polymorphisms
involved in various systems and pathways which may affect
atherosclerosis, the prospect is daunting. An editorial in 
The Lancet drew attention to concerns about association
studies (Anon, 2003). “In the post-human genome era it is
no longer acceptable for The Lancet to publish manuscripts
that imply a genetic association with disease yet fail to iden-
tify the causative genetic variant”. The size and validity of
the positive studies which that Journal has published have
also been questioned. Hirschhorn and colleagues looked 
at over 600 positive associations and found that although 
92 associations were replicated at least once, only 6 of 166
associations that had been repeatedly studied were replicated
in more than 75% of subsequent studies (Hirschhorn et al.,
2002). This is all part of the “problems of reporting genetic
associations with complex outcomes” (Colhoun et al., 2003).
Then there is the bind of positive publication bias and the
pitfalls of meta-analysis. In addition, it may be that it is
haplotypic combinations of polymorphisms which con-
tribute most to risk and so analyses are required which take
multiple polymorphisms into account (Hirschhorn et al.,
2002). Similarly in a review of 55 meta-analyses, it was
shown (Ionannidis et al., 2003) that: “Typically, large
studies and subsequent research suggested weak associations
or no association at all, compared to strong associations
proposed by smaller studies and first research”. This could
be due to bias or heterogeneity. To compound this com-
plexity it is known that the expression of some genes
affecting lipid metabolism is age dependent (Snieder et al.,
1997). As a preliminary strategy to actual gene finding, it
might be helpful to first establish the (joint) genetic archi-
tecture of the coronary risk factors in twin studies.
Twin Studies
Familial clustering of disease in families is well recognized;
for example, Osler (1910) described a family in which three
generations had been afflicted with angina pectoris 
(he actually reported the family’s surname!). Twins represent
a very special resource to investigate the causes of this clus-
tering: twins share intrauterine environment and age;
monozygotic (MZ) twins nearly always share all their genes
and dizygotic (DZ) twins share, on average, 50% of their
segregating genes. As Boomsma et al. (2002) stated, “By
facilitating comparisons between MZ and DZ twins, twin
registers represent some of the best resources for evaluating
the importance of genetic variation in the susceptibility to
disease.” They are also an excellent resource for studying the
significance of genotype × environment interactions. Allied
to this are the recent advances in statistical modelling which
allow the simultaneous analysis of many variables. 
In the Swedish Twin Registry, 21,004 twins or pairs were
investigated for the risk of death from CHD (Marenberg et
al., 1994). Relative hazard estimates were obtained in a mul-
tivariate survival analysis. The study assessed the relative
hazard of a twin’s death from CHD when the other twin had
died of CHD before the age of 55 years, as compared with
the hazard when the twin survived beyond the age of 55
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years. The relative hazard in MZ twins was roughly double
that of DZ twins and, although the effect was attenuated 
by age, it persisted into old age. A more recent report
(Lichtenstein et al., 2002) from the same registry has extoll-
ed it as a unique resource for clinical, epidemiological and
genetic studies. Further follow-up of this cohort, in an
attempt to quantify more accurately the genetic and envi-
ronmental components of CHD death, confirmed the
genetic contribution and also found that these genetic effects
were less likely to diminish with age than previously reported
(Zdravkovic et al., 2002). The next step should be the incor-
poration of environmental exposure data to permit more
accurate quantification of the genetic and environmental
risks. Perhaps the most powerful “natural experiment”
design of all is that of “twin adoption” in MZ pairs. Here
the twins are separated early in life and the effects of differ-
ent environments can be uniquely studied (De Faire et al.,
1975). A variant of this is when MZ twins are discordant for
a certain “environmental” factor. Haapanen et al. (1989)
studied 50 pairs of MZ twins who were discordant for
smoking, a major risk factor for CHD. Carotid artery ath-
erosclerotic plaques were significantly larger in the smokers.
Similarly, Jartti et al. (2002) in The Finnish Twin Cohort,
compared pairs who were discordant for remaining in
Finland or migrating to Sweden at least 20 years before.
Although there was no difference in carotid intima-media
thickness, in MZ twins who migrated to Sweden endothe-
lial function was significantly better, and this difference was
independent of the classic risk factors. This suggests that
lifestyle influences were at work, but the effect of other
unknown factors cannot be excluded. Studying MZ and
DZ twins under different conditions (e.g., laboratory
stress) seems to reveal that the influence of genetic factors
increases during stress, which constitutes evidence for geno-
type  environment interaction (Boomsma et al, 1998). In
both Dutch and Australian twins, an effect of the alpha-1-
antitrypsin gene was found for blood pressure assessed
during stress, but not during rest (Boomsma et al., 1991).
Heritability of Risk Factors in Twin Studies
Comparing the resemblance of MZ twins for a trait with
the resemblance of DZ twins offers an estimate of the
extent to which genetic and environmental variation deter-
mines phenotypic variation of that trait (Boomsma et al.,
2002). These estimates may vary across sex, age or country,
although the latter possibility has seldom been addressed.
The participation of several large twin cohorts in Genom-
EUtwin affords the unique opportunity to compare the
heritability of various cardiovascular risk factors in different
twin populations. This is demonstrated for resting arm cuff
systolic (SBP) and diastolic blood pressure (DBP) in Table
1. These heritabilities summarize blood pressure data from
more than 4000 twin pairs from six different countries.
The striking result immediately apparent is the congru-
ence of the results across the 6 participating countries.
Heritabilities of resting blood pressure are between 44 and
66% across samples for DBP. For SBP, the range of esti-
mates is even narrower at between 52 and 66%. Given the
huge number of twin pairs (see Appendix for details) used
in these analyses we may confidently assert that 50% of the
amount of variance in blood pressure is due to genetic
factors. Shared environmental factors do not seem to play
an important role, except possibly in Finland. 
Twin studies have also yielded evidence for the heritabil-
ity of many other CHD risk factors. For many lipid factors,
particularly lipoprotein(a), the heritability is substantial
(Snieder et al., 1999). In a UK heritability study of haemo-
static factor levels, de Lange et al., showed (2001) that
genetic factors accounted for about 41–75% of the variation.
Another related phenotype to blood pressure is pulse wave
velocity or augmentation, a measure of vascular resistance
and this too was found to be strongly heritable (Snieder 
et al., 2000). Similarly, it has been calculated (Boomsma 
et al., 1994) in Dutch twin pairs that smoking initiation was
influenced by genetic factors (39%) and shared environmen-
tal influences (54%). In smokers, genetic factors determined 
a staggering 86% of the amount smoked (Koopmans et al.,
1999). In male British doctors aged under 45 years who
Table 1
Maximum Likelihood Estimates of Twin Correlations (r) and Heritability (h2) with 95% Confidence Intervals (CI), 
Based on Age and Sex Adjusted Data
MZM DZM MZF DZF DOS h2
r 95% CIs r 95% CIs r 95% CIs r 95% CIs r 95% CIs 95% CIs
SBP
Australia 0.47 0.29 0.64 0.15 –0.25 0.49 0.55 0.45 0.63 0.28 0.08 0.43 0.17 –0.05 0.37 0.52 0.44 0.59
Denmark 0.60 0.49 0.70 0.32 0.17 0.46 0.70 0.61 0.77 0.46 0.33 0.57 0.66 0.60 0.71
Finland 0.45 0.31 0.57 0.33 0.21 0.44 0.50 0.36 0.62 0.43 0.29 0.55 0.53 0.46 0.60
Netherlands 0.50 0.34 0.63 0.25 0.03 0.45 0.47 0.33 0.60 0.36 0.18 0.52 0.26 0.05 0.45 0.54 0.44 0.62
Sweden 0.51 0.27 0.70 0.28 0.05 0.47 0.51 0.30 0.67 0.28 0.11 0.44 0.54 0.41 0.65
UK 0.56 0.50 0.62 0.27 0.22 0.33 0.53 0.48 0.58
DBP
Australia 0.47 0.30 0.60 0.23 –0.10 0.50 0.53 0.43 0.61 0.39 0.21 0.54 0.20 0.00 0.38 0.51 0.44 0.58
Denmark 0.63 0.52 0.71 0.31 0.15 0.45 0.71 0.62 0.78 0.43 0.30 0.54 0.66 0.60 0.71
Finland 0.40 0.26 0.53 0.29 0.17 0.40 0.50 0.35 0.62 0.38 0.24 0.51 0.47 0.39 0.54
Netherlands 0.51 0.35 0.64 0.28 0.06 0.47 0.46 0.31 0.59 0.30 0.11 0.47 0.22 0.01 0.41 0.53 0.44 0.61
Sweden 0.24 –0.05 0.49 0.31 0.09 0.50 0.50 0.30 0.67 0.16 –0.02 0.33 0.44 0.29 0.56
UK 0.49 0.42 0.55 0.23 0.18 0.29 0.48 0.42 0.53
smoked heavily, coronary mortality was 15 times greater
than in non-smokers (Doll & Peto, 1976), which suggests
that a genetic predisposition of smokers to tobacco addic-
tion, making it nearly impossible for them to quit, could be
a major determinant of premature CHD fatality. 
Addressing the Life Course Events Hypothesis in Twin Studies
It has been observed, “that hypotheses based on multiple
observed associations, such as that pertaining to life course
events” (Elford et al., 1992) should be rigorously tested and
several advocates of the hypothesis have recently accepted
that genetic studies give scope to assess the interactive
effects of genes and environment over the life course (Kuh
et al., 2003). Twin studies provide an elegant means to
realize this objective. The accumulating evidence that
CHD begins in early life has moved some of the focus of
the research from factors acting in middle age to exposures
at other periods of life. This approach has now developed
into the “life course” epidemiological perspective, which
recognizes that lifelong experiences, extending from the
antenatal period through childhood, adolescence and adult-
hood, constitute a longitudinal and dynamic exposure
within which the risk of chronic disease evolves (Kuh &
Ben Shlomo, 1997). 
The life course perspective pertaining to CHD thus rec-
ognizes three hypotheses:
1. CHD and coronary risk factors have their origins in
early life exposures. Barker (1998) has demonstrated
the importance of the fetal development — “program-
ming” — for later risk, and factors acting throughout
childhood up to early adulthood also independently
influence later risk (McCarron & Davey Smith, 1998).
2. CHD disease risk evolves over the life course and 
the influence of specific factors is often conditioned 
by the presence of other (later) exposures (Frankel et al.,
1996).
3. Genetic and environmental factors (including social
and behavioural exposures) interact to cause disease. 
The GenomEUtwin population-based twin cohorts facili-
tate the identification of disease alleles, enabling testing of
the effect of any identified variant at the population level,
as well as investigating the effect of life course events. The
well-documented advantages of these cohorts, including
tight matching on age and early life environment, point to
the potential of this research. 
Early concerns that twins were unsuitable candidates
for studying the role of fetal development and, therefore, 
a poor model for studying health have been largely proven
unfounded. The hypothesis that because of the special
intrauterine experiences and conditions of twinning, the
causal pathways of a number of diseases could be different
from that of singletons, and the additional belief that twins
would be more vulnerable to adult chronic diseases were
refuted by the observation that similar rates of all-cause and
cardiovascular disease mortality occur in singletons and
twins (Christensen et al., 2001; Vagero & Leon, 1994). 
An important component of the life course perspective
is investigation of the early life period — often understood
to denote fetal life. Twin studies will be important for eval-
uating the programming hypothesis by (Barker, 1998)
investigating a range of variables in relation to fetal growth.
To date, the characteristic that has been most studied 
is blood pressure. Until recently the data pointed to the
conclusion that low birthweight is a risk factor for high
blood pressure in later life, but more recent rigorous assess-
ment of the earlier studies has led to the suggestion that the
earlier findings stemmed from the impact of random error,
selective emphasis of particular results, and inappropriate
adjustment for current weight and confounding factors
(Huxley et al., 2002). In view of the ongoing debate on the
role of birthweight in determining adult blood pressure it is
of interest that the findings from twin studies have been
conflicting (Poulter et al., 1999; Christensen et al., 2001).
Ijzerman et al. (2000) showed in Dutch adolescent twins
whose mothers had reported their birthweight, that the
association of low birthweight and high blood pressure was
due to common genetic influences. While small sample
sizes and maternally-reported birthweight could have been
responsible for some of the inconsistencies, the possibility
remains that a combination of genetic, maternal, and envi-
ronmental factors during childhood and adolescence,
associated with fetal growth may have influenced the previ-
ously reported associations. Similarly, the twin-pair design
can also be used to investigate whether low birthweight 
is associated with increased risk of CHD. Such a study 
has been carried out in Sweden (Hubinette et al., 2001)
where, in a case-control design of 132 same-sex twin pairs
discordant for myocardial infarction and 118 individually
matched control twin pairs, there was no within-pair asso-
ciation between birth characteristics and risk of myocardial
infarction. Clearly, further research is required to improve
understanding of the causal pathways and, therefore, inves-
tigation of these hypotheses using the much larger numbers
of twins in GenomEUtwin should help to elucidate the
associations between birth characteristics and subsequent
risk of CHD. 
Extension of such an investigation to the consideration
of the impact of ‘catch-up’ growth in childhood would be 
a significant advance in unravelling early life antecedents of
CHD. While it has been hypothesized that different paths
of early growth may explain the heterogeneity among indi-
viduals to coronary risk, there are few empirical data and,
as with the study of fetal growth, twin cohorts which have
collected growth data are ideally placed to contribute 
to this debate. CHD, which usually manifests itself in later
life can be defined as an age-specific trait. Characterizing
such traits requires information on factors, not just early 
in life, but over long periods (e.g., many decades). Risk factor
profiles change throughout an individual’s life span, necessi-
tating knowledge of the status of these characteristics at
multiple time points. Longitudinal data, when used 
in analyses of a twin cohort — and ultimately, combined
with genotypic information — could provide valuable oppor-
tunities to learn how traits are affected by age-genotype and
gene  environment interactions over time. Large samples, 
as available in GenomEUtwin, are needed because of the
requirement to distinguish among age groups and because of
the genetic complexity of many disease traits. Moreover, the
availability of data from cohorts dating back to the late 19th
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century will allow assessment of how trends in environmen-
tal exposures have contributed to genetic expression.
More complex yet, but likely to provide a truer assess-
ment of the role of life course exposures will involve
investigation of the genetic and environmental contribution
to QTL expression or rate-of-change traits (NIA Aging and
Genetic Epidemiology Working Group, 2000) over the lifes-
pan. A small number of twin studies which have broached
this issue have yielded evidence that genetic factors signifi-
cantly affect rates of change with age in several physiological
measures, including lipids (Snieder et al., 1997) adiposity
and lipid profile (Korkeila et al., 1995; Austin et al., 1997),
and change and stability of body mass index (Fabsitz et al.,
1992; Friedlander et al., 1997).
Conclusions 
There is now overwhelming evidence for genetic predisposi-
tion to CHD. We have long been aware that the trends 
in incidence and mortality from CHD vary greatly, not only
just by country but also over time, suggesting that although
genotype may determine risk in susceptible individuals
under specific exposures, it is the broader environmental
factors which drive these trends. Twin studies have contrib-
uted a great deal to our knowledge in establishing the
heritable nature of various CHD risk factors. The findings
on the heritability of blood pressure in the present study
from twin registries in several countries, add to those of pre-
vious reports (Hong et al., 1994; Iliadou et al., 2002; Snieder
et al., 2003). Indeed, the present results from these registries
demonstrate a remarkable degree of coherence, although this
may reflect a similarity between these northern European
populations, and could differ in other populations. The
finding of similar heritabilities in African-Americans
(Snieder et al., 2003) suggests that this is unlikely.
Genetic factors may influence not only physiological
functions at one point in time but also their rates of change 
over time (period and/or cohort), which may in turn influ-
ence whether and when disease occurs. In addition to
environmental factors, which clearly are operating, the effect
of various “variability genes” may be acting independently
of the genetic influences on the absolute levels of these 
risk factors. 
Several other related research questions which, if answer-
ed, will improve our understanding of the complex and
changing factors that determine coronary health, will be
investigated in GenomEUtwin. Examples include: 
• Are genetic effects fixed regardless of changing environ-
ment over an individual’s lifetime and over generations,
or is there a dynamic interplay between genes and envi-
ronment?
• Can a dynamic concept of heritability (e.g., blood pres-
sure at several time points) elucidate how genetic
factors contribute to evolving health states?
• Which environmental factors, if any, act to switch genes
on and off, and how does this depend on when the
exposure occurred?
One of the GenomEUtwin cohorts is not twin-based:
MORGAM( MOnica, Risk, Genetics, Archiving and Mono-
graph) is a large prospective cohort study of classic risk and
genetic factors in the development of cardiovascular disease
(Evans, 2000). Genotypes identified in the twin cohorts as
conferring cardiovascular risk will be investigated in
MORGAM. Exploitation of the GenomEUtwin cohorts in
this manner should improve our understanding of the life
course paradigm and CHD, and ultimately provide better
epidemiological and genetic methods of tackling this impor-
tant problem.
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Appendix
Genetic Analyses of Blood Pressure Data
Quantitative genetic analyses were carried out to identify and quantify genetic and environmental influences on
variation in blood pressure. Structural equation modeling was used to partition the variances in SBP and DBP into
genetic and environmental components. These models are widely used and described in detail elsewhere (e.g., Neale
& Cardon, 1992) and in this special issue by Posthuma et al. (2003). Each model comprised a set of simultaneous
linear equations specifying the expectations for the degree to which additive genetic (A), dominant genetic (D),
shared-environment (C) and non-shared environment (E) contribute to the phenotypic variation. Covariances
between MZ and DZ male and female twins were modeled as a function of additive genetic influences (since the
twin correlations did not indicate the presence of genetic dominance) and of a common environment shared by
family members. The model for the means included a linear regression of age and sex, and was simultaneously
modeled with the partitioning of the variance in all countries. Before conducting the genetic modeling, maximum
likelihood correlations were computed to estimate the degree of similarity in blood pressure between members of
MZ and DZ twin pairs. These correlations were stratified by country and zygosity and data were corrected for age
and sex. Correlations were used to guide model selection (ACE, ADE) for the biometric analyses. An ACE model
was always chosen. Sex-differences in the variance components were explored through a series of hierarchical proce-
dures. Two types of sex differences were analyzed: sex-differences in the magnitude of the genetic and environmental
variance components and sex differences in the set of genes which influence variation in blood pressure in males and
females. This last test was only possible for countries that supplied data on opposite-sex twin pairs. Results (not
reported in the Tables) indicated that the same genes are expressed in males and females. Throughout, the signifi-
cance of specific parameters is assessed using Chi-square difference testing and comparing nested models. All models
are nested under the full ACE model which allowed means and covariances to be different for all zygosity by sex by
country groups. Models were fitted to the raw data. This allowed the data from incomplete twin pairs to be ana-
lyzed as well. Although incomplete pairs do not provide information on twin covariances, they are still informative
for some of the parameter estimates (e.g., the regression of blood pressure on age and sex, and to obtain estimates of
blood pressure variances). Table A gives an overview of the number of participants in all countries and their average
ages. Tables B and C provide the main fit statistics for systolic and diastolic blood pressure. These tables clearly show
the absence of sex differences in the relative contributions of genetic and environmental factors to blood pressure
variance. Also, they indicate the absence of a significant effect of shared family environment (with the exception of
the Finnish data). The absence of an effect of shared family environment is demonstrated even more clearly in Table
D. This table shows the estimates of the variance components and the standardized genetic component (i.e., heri-
tability) for the ACE and AE model. The point estimates for the variance of shared environment is small, or even
zero. The small decrease in goodness-of-fit when this component is removed from the model indicates its non-sig-
nificant contribution to the total variance in blood pressure. Table D also shows the large differences in the absolute
sizes of the genetic and environmental variance components. There is a clear trend that variances are larger in the
older samples. However, there is an increase in both the genetic and environmental variance components so that
heritability estimates remain very similar.
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Table A
Number of Twins and Complete Twin Pairs by Country
Number of twin pairs (twin 1, twin 2, complete pairs)
MZM DZM MZF DZF DOS (Female, Male) age (range)
SBP
Australia 143 / 127 / 89 79 / 67 / 40 294 / 280 / 222 160 / 142 / 106 182 / 191 / 106
Denmark 153 / 153 / 153 146 / 146 / 146 158 / 158 / 158 167 / 167 / 167
Finland 151 / 151 / 151 236 / 236 / 236 122 / 122 / 122 155 / 155 / 155
Netherlands 100 / 99 / 99 78 / 78 / 78 125 / 126 / 124 100 / 100 / 98 87 / 84 / 84
Sweden 46 / 45 / 45 73 / 73 / 73 63 / 63 / 63 121 / 121 / 121
UK 529 / 532 / 498 1175 / 1189 / 1078
DBP
Australia 143 / 127 / 89 79 / 67 / 40 294 / 280 / 222 160 / 142 / 106 182 / 191 / 106 45.5 (30–86) yr
Denmark 153 / 153 / 153 146 / 146 / 146 158 / 158 / 158 167 / 167 / 167 37.8 (18–66) yr
Finland 151 / 151 / 151 236 / 236 / 236 122 / 122 / 122 155 / 155 / 155 58.6 (37–76) yr
Netherlands 100 / 99 / 99 78 / 78 / 78 125 / 126 / 124 100 / 100 / 98 87 / 84 / 84 32.2 (13–71) yr
Sweden 46 / 45 / 45 73 / 73 / 73 63 / 63 / 63 120 / 119 / 118 65.2 (43–86) yr
UK 529 / 532 / 498 1175 / 1189 / 1078 46.6 (18–79) yr
Table B
Model Fit Statistics for Systolic Blood Pressure: ACE, AE, CE and E with or without Sex Differences in Parameter Estimates for Variance
Components
SBP minus 2 times LL df ∆χ2 df p AIC
Australia
full model 13394.003 1656
ACE no sex 13397.045 1659 3.042 3 0.385 –2.958
AE no sex 13397.045 1660 3.042 4 0.551 –4.958
CE no sex 13417.300 1660 23.297 4 0.000 15.297
E no sex 13503.750 1661 109.747 5 0.000 99.747
Denmark
full model 9782.949 1239
ACE no sex 9788.642 1242 5.693 3 0.128 –0.307
AE no sex 9790.032 1243 7.083 4 0.132 –0.917
CE no sex 9815.555 1243 32.606 4 0.000 24.606
E no sex 10010.852 1244 227.903 5 0.000 217.903
Finland
full model 11681.327 1319
ACE no sex 11683.199 1322 1.872 3 0.599 –4.128
AE no sex 11690.144 1323 8.817 4 0.066 0.817
CE no sex 11687.506 1323 6.179 4 0.186 –1.821
E no sex 11816.971 1324 135.644 5 0.000 125.644
Netherlands
full model 7280.963 968
ACE no sex 7283.365 971 2.402 3 0.493 –3.598
AE no sex 7283.365 972 2.402 4 0.662 –5.598
CE no sex 7297.825 972 16.862 4 0.002 8.862
E no sex 7366.911 973 85.947 5 0.000 75.947
Sweden
full model 5343.547 596
ACE no sex 5343.910 599 0.363 3 0.948 –5.637
AE no sex 5343.926 600 0.379 4 0.984 –7.621
CE no sex 5351.243 600 7.696 4 0.103 –0.304
E no sex 5392.705 601 49.158 5 0.000 39.158
UK (females only)
ACE 28754.707 3420
AE 28755.361 3421 0.654 1 0.419 –1.346
CE 28785.747 3421 31.04 1 0.000 29.040
E 29007.962 3422 253.255 2 0.000 249.255
Note: Full model is ACE model with sex differences in variance components, this is the model against which other models are compared (except for UK where only women 
participated); “no sex” means models without sex differences in variance components (see methods).
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Table C
Model Fit Statistics for Diastolic Blood Pressure: ACE, AE, CE and E with or Without Sex Differences in Parameter 
Estimates for Variance Components
DBP minus 2 times LL df ∆χ2 df p AIC
Australia
full model 12360.137 1656
ACE no sex 12365.459 1659 5.321 3 0.149 –0.679
AE no sex 12365.861 1660 5.724 4 0.221 –2.276
CE no sex 12376.096 1660 15.959 4 0.003 7.959
E no sex 12485.663 1661 125.526 5 0.000 115.526
Denmark
full model 8972.207 1239
ACE no sex 8976.159 1242 3.952 3 0.267 –2.048
AE no sex 8977.320 1243 5.113 4 0.276 –2.887
CE no sex 9004.827 1243 32.620 4 0.000 24.620
E no sex 9205.194 1244 232.988 5 0.000 222.988
Finland
full model 10156.516 1319
ACE no sex 10180.340 1322 23.825 3 0.000 17.825
AE no sex 10185.493 1323 28.978 4 0.000 20.978
CE no sex 10182.871 1323 26.356 4 0.000 26.356
E no sex 10280.938 1324 124.423 5 0.000 114.423
Netherlands
full model 6846.121 968
ACE no sex 6846.404 971 0.283 3 0.963 –5.717
AE no sex 6846.404 972 0.283 4 0.991 –7.717
CE no sex 6860.294 972 14.173 4 0.006 6.173
E no sex 6934.803 973 88.682 5 0.000 78.682
Sweden
full model 4459.590 593
ACE no sex 4460.672 596 1.083 3 0.781 –4.917
AE no sex 4460.672 597 1.083 4 0.897 –6.917
CE no sex 4465.166 597 5.576 4 0.233 –2.424
E no sex 4490.507 598 30.917 5 0.000 20.917
UK (females only)
ACE 26061.370 3422
AE 26061.370 3423 0.000 1 1.000 –2.000
CE 26090.231 3423 28.862 1 0.000 26.862
E 26249.152 3424 187.783 2 0.000 183.783
Note: Full model is ACE model with sex differences in variance components. This is the model against which other models are compared (except for UK where only women 
participated); “no sex” means models without sex differences in variance components (see methods).
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Table D
Estimates for Genetic, Shared and Non-shared Environmental Variance Components for Age-corrected Diastolic and Systolic Blood Pressure
SBP DBP
Model Va Vc Ve h2 ∆ χ21 Model Va Vc Ve h2 ∆ χ21
Australia 0.000 0.403
ACE 101.08 0.00 94.66 52.0% ACE 45.32 8.29 51.85 43.0%
AE 101.08 94.66 52.0% AE 54.18 51.12 51.0%
Denmark 1.390 1.163
ACE 94.72 20.86 62.43 53.0% ACE 50.90 10.09 32.12 55.0%
AE 115.99 60.87 66.0% AE 61.11 31.40 66.0%
Finland 6.945* 5.153*
ACE 104.54 108.26 216.46 24.0% ACE 27.17 30.81 76.84 20.0%
AE 228.05 198.59 53.0% AE 62.91 71.32 47.0%
Netherlands 0.000 0.000
ACE 60.21 0.00 51.45 54.0% ACE 37.60 0.00 33.49 53.0%
AE 60.21 51.45 54.0% AE 37.60 33.49 53.0%
Sweden 0.016 0.000
ACE 228.12 7.68 202.09 53.0% ACE 44.42 0.00 57.59 44.0%
AE 237.23 200.50 54.0% AE 44.42 57.59 44.0%
UK 0.654 0.000
ACE 130.94 14.60 133.47 47.0% ACE 59.10 0.00 65.21 48.0%
AE 147.70 130.74 53.0% AE 59.10 65.21 48.0% 
Note: * p < .05
Variance components estimates are given for the ACE and AE Model (without Sex Differences). The Chi-squared statistic gives the difference in goodness-of-fit
between the ACE and AE Model and indicates that C can nearly always be omitted from the model as an explanation for familial resemblance.
